The store will not work correctly when cookies are disabled.
(+/-)-6-Benzo[b]thiophen-2-yl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole hydrochloride
ID: ALA3092296
PubChem CID: 72737032
Max Phase: Preclinical
Molecular Formula: C13H13ClN2S2
Molecular Weight: 260.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.c1ccc2sc(C3CN4CCSC4=N3)cc2c1
Standard InChI: InChI=1S/C13H12N2S2.ClH/c1-2-4-11-9(3-1)7-12(17-11)10-8-15-5-6-16-13(15)14-10;/h1-4,7,10H,5-6,8H2;1H
Standard InChI Key: JNKSOLVXNYVFGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
23.3199 -5.3846 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
22.7759 -6.4395 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.9912 -6.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9912 -7.5216 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7759 -7.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2607 -7.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2065 -6.4395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7216 -7.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2065 -7.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6271 -6.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6271 -7.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4118 -7.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8965 -7.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4118 -6.4395 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.9111 -7.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1993 -7.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1993 -6.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9111 -6.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
2 6 1 0
7 8 1 0
8 9 1 0
3 7 2 0
4 9 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
10 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
10 18 2 0
11 15 2 0
8 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.39 | Molecular Weight (Monoisotopic): 260.0442 | AlogP: 3.36 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.74 | CX LogP: 3.37 | CX LogD: 3.28 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.78 | Np Likeness Score: -1.06 |
References
1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M.. (2013) Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests., 21 (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053] |